Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Daniel Dedman

7PUBLICATIONS
29CO-AUTHORS
Disease surveillanceOncology and carcinogenesis not elsewhere classifiedToxicology (incl. clinical toxicology)PharmacogenomicsData quality
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

Sort by Publication Date:
|Feb 14, 2024
Pooling of primary care electronic health record (EHR) data on Huntington's disease (HD) and cancer: establishing comparability of two large UK databases.

Daniel Dedman, Rachael Williams, Krishnan Bhaskaran

|Jan 10, 2022
Long-Term Risk of Skin Cancer and Lymphoma in Users of Topical Tacrolimus and Pimecrolimus: Final Results from the Extension of the Cohort Study Protopic Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (JOELLE).

Alejandro Arana, Anton Pottegård, Josephina G Kuiper

|Mar 19, 2021
Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study.

Danielle E Robinson, M Sanni Ali, Victoria Y Strauss

|Mar 18, 2021
The Utilization and Safety of Umeclidinium and Umeclidinium/Vilanterol in UK Primary Care: A Retrospective Cohort Study.

Gema Requena, Daniel Dedman, Jennifer K Quint

|Oct 15, 2020
Approaches for combining primary care electronic health record data from multiple sources: a systematic review of observational studies.

Daniel Dedman, Melissa Cabecinha, Rachael Williams

|May 21, 2020
Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European Countries.

Edith M Heintjes, Irene D Bezemer, Daniel Prieto-Alhambra

Pageof 2

Frequent Collaborators

1 joint publications

Edith M Heintjes

1 joint publications

Melissa Cabecinha

1 joint publications

Jennifer K Quint

1 joint publications

Rebecca E Ghosh

1 joint publications

Danielle E Robinson

1 joint publications

M Sanni Ali

1 joint publications

Victoria Y Strauss

1 joint publications

Leena Elhussein

1 joint publications

Bo Abrahamsen

1 joint publications

Nigel K Arden

Frequent Collaborators

1 joint publications

Edith M Heintjes

1 joint publications

Melissa Cabecinha

1 joint publications

Jennifer K Quint

1 joint publications

Rebecca E Ghosh

Top Related Videos

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
09:06

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease

Published on : Jun 09, 2018

12.2K
Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on : Nov 08, 2015

17.1K
Preparation Of Gushukang (GSK) Granules for In Vivo and In Vitro Experiments
06:16

Preparation Of Gushukang (GSK) Granules for In Vivo and In Vitro Experiments

Published on : May 09, 2019

7.8K
See more related videos

Top Related Videos

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
09:06

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease

Published on : Jun 09, 2018

12.2K
Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on : Nov 08, 2015

17.1K
Preparation Of Gushukang (GSK) Granules for In Vivo and In Vitro Experiments
06:16

Preparation Of Gushukang (GSK) Granules for In Vivo and In Vitro Experiments

Published on : May 09, 2019

7.8K
See more related videos